Guardant Health
GH
#3559
Rank
โ‚น258.94 B
Marketcap
โ‚น2,105
Share price
-1.18%
Change (1 day)
-7.66%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of June 2024 : -โ‚น0.14 B

According to Guardant Health 's latest financial reports the company has -โ‚น0.14 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚น13.21 B165.27%
2022-12-31$โ‚น4.97 B-89.64%
2021-12-31$โ‚น48.06 B-51.43%
2020-12-31$โ‚น98.97 B63.97%
2019-12-31$โ‚น60.36 B65.3%
2018-12-31$โ‚น36.51 B85.31%
2017-12-31$โ‚น19.70 B263.84%
2016-12-31$โ‚น5.41 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น70.17 B-51,961.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น263.77 B-195,024.98%๐Ÿ‡บ๐Ÿ‡ธ USA